Page last updated: 2024-10-25

deferoxamine and Granuloma

deferoxamine has been researched along with Granuloma in 7 studies

Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.

Granuloma: A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents.

Research Excerpts

ExcerptRelevanceReference
" Further, there is lack of agreement about the benefits of deferoxamine (Dfx) in the treatment of anemia and oxidative stress during inflammation and chronic diseases."3.69Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine. ( Mitjavila, MT; Muntané, J; Puig-Parellada, P, 1995)

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19901 (14.29)18.7374
1990's4 (57.14)18.2507
2000's1 (14.29)29.6817
2010's1 (14.29)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdelgelil, NH1
Abdellatif, MZM1
Abdel-Hafeez, EH1
Belal, US1
Mohamed, RM1
Abdel-Razik, AH1
Hassanin, KMA1
Abdel-Wahab, A1
Muntané, J4
Puig-Parellada, P4
Mitjavila, MT5
Fernandez, Y1
Mitjavila, S1
Ródenas, J1
Carbonell, T2
Fritsch, P1
Saiz, MP2
Carbonell, MT1
Sánchez, J1
Chvapil, M1
McCarthy, D1
Madden, JW1
Peacock, EE1

Other Studies

7 other studies available for deferoxamine and Granuloma

ArticleYear
Effects of iron chelating agent on Schistosoma mansoni infected murine model.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 109

    Topics: Animals; Deferoxamine; Disease Models, Animal; Granuloma; Iron Chelating Agents; Liver Cirrhosis; Li

2019
Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine.
    The Journal of laboratory and clinical medicine, 1995, Volume: 126, Issue:5

    Topics: Acute Disease; Anemia, Iron-Deficiency; Animals; Carrageenan; Chronic Disease; Deferoxamine; Disease

1995
Antioxidant defenses and its modulation by iron in carrageenan-induced inflammation in rats.
    Clinica chimica acta; international journal of clinical chemistry, 1993, Feb-28, Volume: 214, Issue:2

    Topics: Animals; Antioxidants; Ascorbic Acid; Carrageenan; Deferoxamine; Disease Models, Animal; Granuloma;

1993
Different roles for nitrogen monoxide and peroxynitrite in lipid peroxidation induced by activated neutrophils.
    Free radical biology & medicine, 2000, Feb-01, Volume: 28, Issue:3

    Topics: Animals; Arginine; Carrageenan; Deferoxamine; Exudates and Transudates; Granuloma; Inflammation; Lip

2000
Modulation of exudate inflammation parameters in rat carrageenan-induced granuloma by modification of exudate iron levels.
    Agents and actions, 1991, Volume: 32, Issue:3-4

    Topics: Animals; Carrageenan; Deferoxamine; Exudates and Transudates; Ferritins; Granuloma; Iron; Iron Chela

1991
Role of iron in carrageenan-induced granuloma: action of desferrioxamine and indometacin.
    Pharmacology, 1990, Volume: 40, Issue:4

    Topics: Animals; Carrageenan; Deferoxamine; Dinoprostone; Exudates and Transudates; Granuloma; Indomethacin;

1990
Effect of 1,10-phenanthroline and desferrioxamine in vivo on prolyl hydroxylase and hydroxylation of collagen in various tissues of rats.
    Biochemical pharmacology, 1974, Volume: 23, Issue:15

    Topics: Animals; Animals, Newborn; Body Weight; Calcium; Carrageenan; Collagen; Deferoxamine; Estradiol; Fem

1974